ILM peeling may modify RNFL thickness

Article

Internal limiting membrane (ILM) peeling surgery causes significant modification of retinal nerve fibre layer (RNFL) thickness, according to researchers at the Ophthalmology Units of the University of Bologna and the Sant'Orsola-Malpighi Polyclinic.

Internal limiting membrane (ILM) peeling surgery causes significant modification of retinal nerve fibre layer (RNFL) thickness, according to researchers at the Ophthalmology Units of the University of Bologna and the Sant'Orsola-Malpighi Polyclinic.

The researchers conducted a single-centre, prospective, interventional consecutive case series of 30 eyes in 30 patients who had ILM peeling for idiopathic macular hole or epiretinal membrane. Prior to the surgery and at 1, 3 and 6 months post surgery the patients received a complete ophthalmic exam, fundus images were taken and spectral domain optical coherence tomography was performed. RNFL thickness was evaluated in the superotemporal, temporal, inferotemporal, inferonasal, nasal and superonasal sectors, as well as globally. Visual field testing was performed prior to the surgery and at the 6-month postoperative follow up.

One month after ILM peeling surgery there was a diffuse increase in RNFL thickness, but the nerve fibre layer had returned to preoperative values at the 3-month follow-up. However, at 6 months post-surgery, the RNFL thickness in the superotemporal, inferotemporal and temporal sectors was lower than basal values (P P P

The researchers found no correlation between the RNFL thickness and the patients' visual field indices.

According to the researchers, the increase in RNFL thickness seen 1 month postoperatively could have been caused by inflammatory responses. However, the reduction of RNFL thickness found in the temporal sectors at 6 months postoperatively could demonstrate that the ILM peeling caused damage to the RNFL.

The study was published in Retina. To view the abstract, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.